The US FDA and the generics industry may need to increase awareness efforts so drug master file (DMF) sponsors take full advantage of the available resources to discuss problems with their applications.
Industry representatives complained to FDA officials during a June 29 quarterly meeting on implementation of the generic drug user fee...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?